Business Description
Astec Lifesciences Ltd
ISIN : INE563J01010
Total Employee Number:
555Compare
Compare
Traded in other countries / regions
ASTEC.India IPO Date
2009-11-25Description
Astec Lifesciences Ltd manufactures & distributes a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company's products include agrochemicals, such as Triazole Fungicides, Herbicides, and Insecticides. The company is also into Intermediates & Specialty chemicals. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.42 | |||||
Debt-to-Equity | 1.15 | |||||
Debt-to-EBITDA | -289.74 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2 | |||||
Beneish M-Score | -1.89 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -13 | |||||
3-Year FCF Growth Rate | -23.2 | |||||
3-Year Book Growth Rate | -6.2 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 26.62 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 18.01 | |||||
9-Day RSI | 30.5 | |||||
14-Day RSI | 39.67 | |||||
3-1 Month Momentum % | 32.34 | |||||
6-1 Month Momentum % | 4.1 | |||||
12-1 Month Momentum % | -21.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.89 | |||||
Quick Ratio | 0.61 | |||||
Cash Ratio | 0.03 | |||||
Days Inventory | 193.13 | |||||
Days Sales Outstanding | 144.35 | |||||
Days Payable | 107.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.1 | |||||
Shareholder Yield % | -7.22 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 33.41 | |||||
Operating Margin % | -11.03 | |||||
Net Margin % | -18.06 | |||||
EBITDA Margin % | -0.35 | |||||
FCF Margin % | -19.24 | |||||
OCF Margin % | -18.01 | |||||
ROE % | -23.36 | |||||
ROA % | -8.97 | |||||
ROIC % | -5.91 | |||||
3-Year ROIIC % | -83.97 | |||||
ROC (Joel Greenblatt) % | -6.2 | |||||
ROCE % | -9.34 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 73.32 | |||||
Shiller PE Ratio | 100.23 | |||||
PS Ratio | 3.44 | |||||
PB Ratio | 4.07 | |||||
Price-to-Tangible-Book | 4.35 | |||||
EV-to-EBIT | -43.61 | |||||
EV-to-EBITDA | -1307.66 | |||||
EV-to-Revenue | 4.52 | |||||
EV-to-FCF | -23.8 | |||||
Price-to-GF-Value | 0.73 | |||||
Price-to-Median-PS-Value | 0.91 | |||||
Earnings Yield (Greenblatt) % | -2.28 | |||||
FCF Yield % | -5.43 | |||||
Forward Rate of Return (Yacktman) % | 5.95 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Astec Lifesciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 4,481.456 | ||
| EPS (TTM) (₹) | -38.592 | ||
| Beta | 1.2404 | ||
| 3-Year Sharpe Ratio | -0.3 | ||
| 3-Year Sortino Ratio | -0.47 | ||
| Volatility % | 56.72 | ||
| 14-Day RSI | 39.67 | ||
| 14-Day ATR (₹) | 35.543424 | ||
| 20-Day SMA (₹) | 764.79 | ||
| 12-1 Month Momentum % | -21.76 | ||
| 52-Week Range (₹) | 513.4 - 978.3 | ||
| Shares Outstanding (Mil) | 22.28 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Astec Lifesciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Astec Lifesciences Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Astec Lifesciences Ltd Frequently Asked Questions
What is Astec Lifesciences Ltd(NSE:ASTEC)'s stock price today?
The current price of NSE:ASTEC is ₹713.65. The 52 week high of NSE:ASTEC is ₹978.30 and 52 week low is ₹513.40.
When is next earnings date of Astec Lifesciences Ltd(NSE:ASTEC)?
The next earnings date of Astec Lifesciences Ltd(NSE:ASTEC) is .
Does Astec Lifesciences Ltd(NSE:ASTEC) pay dividends? If so, how much?
Astec Lifesciences Ltd(NSE:ASTEC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Astec Lifesciences Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers